For the second time in the last four months, pharmaceutical Bristol-Myers Squibb is announcing a major recall of its Avalide blood pressure tablets distributed on the U.S. mainland and Puerto Rico.
On Thursday, the company announced it will be collecting 64 million tablets due to the potential for reduced effectiveness, Reuters reported. The medication was produced at Bristol’s plants in Humacao and Evansville, Indiana.
Bristol-Myers said the action was a “precautionary measure.
In September, the pharmaceutical — which jointly markets the drug with Sanofi-Aventis — recalled 62 lots, or 60 million tablets, of the drug manufactured in Puerto Rico.
Avalide, sold under the brand name Avapro, is one of Bristol-Myers’ blockbuster products, with $1.3 billion in sales in 2009.